160.3K
XNAS Volume
High vol.+gain this week
XNAS 19 Mar, 2025 2:56 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Michael Ferguson | Director | 30 Dec 2024 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | ||
| Christopher M. Fashek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| Stephen R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
| Harold Jacob | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 10,000 | 10,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 23,000 | 23,000 | - | - | Option to Purchase Common Stock | |
| Brian M. Murphy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 80,000 | 80,000 | - | - | Option to Purchase Common Stock | |
| Aurora Cassirer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Dec 2024 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
| Maria Schroeder | Director | 30 Dec 2024 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | ||
| Cassirer Aurora | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 16,667 | 16,667 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 16,667 | 16,667 | - | - | Option to Purchase Common Stock | |
| Ferguson Michael | Director | 23 Jan 2024 | 16,666 | 16,666 | - | - | Option to Purchase Common Stock | ||
| Schroeder Maria | Director | 23 Jan 2024 | 16,667 | 16,667 | - | - | Option to Purchase Common Stock | ||
| Thomas R. Mika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 16,666 | - | - | Option to Purchase Common Stock | |
| Harold Jacob | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 6,667 | 6,667 | - | - | Option to Purchase Common Stock | |
| Ferguson Michael | Director | 15 Nov 2023 | 2,875 | 0 | - | - | Option to Purchase Common Stock | ||
| Aurora Cassirer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| R. Thomas Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 3,000 | 0 | - | - | Option to Purchase Common Stock | |
| R. Stephen Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| Stephen Brown R. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 14,000 | 14,000 | - | - | Option to Purchase Common Stock | |
| Ferguson Michael | Director | 15 Nov 2023 | 2,875 | 0 | - | - | Option to Purchase Common Stock | ||
| Brian M. Murphy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 15 Nov 2023 | 4,250 | 0 | - | - | Option to Purchase Common Stock | ||
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 3,333 | 3,333 | - | - | Option to Purchase Common Stock | |
| Harold Jacob | Director, Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 3,333 | 3,333 | - | - | Option to Purchase Common Stock | |
| M. Christopher Fashek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 14,000 | 14,000 | - | - | Option to Purchase Common Stock | |
| R. Thomas Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 1,500 | 0 | - | - | Option to Purchase Common Stock | |
| Jacob Harold | Director, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| Aurora Cassirer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 3,333 | 3,333 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,000 | 0 | - | - | Option to Purchase Common Stock | |
| Goldstein Martin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| Murphy M. Brian | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 1,875 | 0 | - | - | Option to Purchase Common Stock | |
| Goldstein Martin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 1,500 | 0 | - | - | Option to Purchase Common Stock | |
| R. Thomas Mika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2023 | 3,334 | 3,334 | - | - | Option to Purchase Common Stock | |
| Goldstein Martin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| Ferguson Michael | Director | 15 Nov 2023 | 3,334 | 3,334 | - | - | Option to Purchase Common Stock | ||
| Murphy Brian M. | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| Fashek M. Christopher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Options to Purchase Common Stock | |
| R. Stephen Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 5,000 | 0 | - | - | Option to Purchase Common Stock | |
| Stephen Brown R. | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 563 | 0 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 15 Nov 2023 | 1,750 | 0 | - | - | Option to Purchase Common Stock | ||
| Schroeder Maria | Director | 15 Nov 2023 | 3,333 | 3,333 | - | - | Option to Purchase Common Stock | ||
| M. Fashek Christopher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 4,000 | 0 | - | - | Options to Purchase Common Stock | |
| M. Brian Murphy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 15,000 | 0 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 4,575 | 0 | - | - | Option to Purchase Common Stock | |
| Jacob Harold | Director, Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| M. Fashek Christopher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 6,000 | 0 | - | - | Options to Purchase Common Stock | |
| Murphy Brian M. | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 10,000 | 0 | - | - | Option to Purchase Common Stock | |
| R. Thomas Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 4,500 | 0 | - | - | Option to Purchase Common Stock | |
| M. Christopher Fashek | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 1,125 | 0 | - | - | Options to Purchase Common Stock | |
| Maria Schroeder | Director | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | ||
| Goldstein Martin | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 3,000 | 0 | - | - | Option to Purchase Common Stock | |
| Fashek M. Christopher | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,100 | 0 | - | - | Options to Purchase Common Stock | |
| Martin Goldstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 1,125 | 0 | - | - | Option to Purchase Common Stock | |
| Brown Stephen R. | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 2,500 | 0 | - | - | Option to Purchase Common Stock | |
| Thomas Mika R. | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 15 Nov 2023 | 3,000 | 0 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Purchase of securities on an exchange or from another person at price $ 0.25 per share. | 05 Jan 2023 | 50,000 | 50,000 (1%) | 1% | 0.3 | 12,500 | Common Stock |
| Christopher M. Fashek | Director | Purchase of securities on an exchange or from another person at price $ 0.60 per share. | 15 Jun 2022 | 40,000 | 75,000 (1%) | 1% | 0.6 | 23,828 | Common Stock |
| Stephen R. Brown | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.57 per share. | 14 Jun 2022 | 4,000 | 4,000 (0%) | 0% | 0.6 | 2,296 | Common Stock |
| Aurora Cassirer | Director | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 01 Jun 2022 | 2,000 | 2,000 (0%) | 0% | 0.7 | 1,380 | Common Stock |
| Stephen R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2021 | 100,000 | 100,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2021 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 29 Dec 2021 | 57,500 | 57,500 | - | - | Option to Purchase Common Stock | ||
| Christopher M. Fashek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 120,000 | 120,000 | - | - | Option to Purchase Common Stock | |
| Stephen R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 90,000 | 90,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 60,000 | 60,000 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 22 Dec 2020 | 85,000 | 85,000 | - | - | Option to Purchase Common Stock | ||
| Brian M. Murphy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2020 | 200,000 | 200,000 | - | - | Option to Purchase Common Stock | |
| Christopher M. Fashek | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 45,000 | 0 | - | - | Option to Purchase Common Stock | |
| Christopher M. Fashek | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 91,679 | 0 | - | - | Option to Purchase Common Stock | |
| Stephen R. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 22,500 | 0 | - | - | Option to Purchase Common Stock | |
| Stephen R. Brown | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 61,000 | 0 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 30,000 | 0 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 20,000 | 0 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 20,000 | 0 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 22,083 | 0 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 32,500 | 0 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 22,500 | 0 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 20,417 | 0 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 22,500 | 0 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 20,000 | 0 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 02 Nov 2020 | 21,250 | 0 | - | - | Option to Purchase Common Stock | ||
| Michael Ferguson | Director | 02 Nov 2020 | 20,000 | 0 | - | - | Option to Purchase Common Stock | ||
| Michael Ferguson | Director | 02 Nov 2020 | 20,000 | 0 | - | - | Option to Purchase Common Stock | ||
| Michael Ferguson | Director | 02 Nov 2020 | 27,500 | 0 | - | - | Option to Purchase Common Stock | ||
| Michael Ferguson | Director | 02 Nov 2020 | 27,500 | 0 | - | - | Option to Purchase Common Stock | ||
| Brian M. Murphy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 183,359 | 0 | - | - | Option to Purchase Common Stock | |
| Brian M. Murphy | Director, Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Nov 2020 | 75,000 | 0 | - | - | Option to Purchase Common Stock | |
| Christopher M. Fashek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| Stephen R. Brown | SVP, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 40,000 | 40,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 30,000 | 30,000 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 01 Oct 2020 | 35,000 | 35,000 | - | - | Option to Purchase Common Stock | ||
| Brian M. Murphy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 50,000 | 50,000 | - | - | Option to Purchase Common Stock | |
| Christopher M. Fashek | Director | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 29 Sep 2020 | 10,000 | 10,000 (0%) | 0% | 0.8 | 7,887 | Common Stock |
| Thomas R. Mika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2020 | 30,000 | 30,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jul 2020 | 22,500 | 22,500 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 13 Jul 2020 | 27,500 | 27,500 | - | - | Option to Purchase Common Stock | ||
| Christopher M. Fashek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2020 | 42,000 | 42,000 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2019 | 30,000 | 30,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2019 | 22,500 | 22,500 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | Director | 04 Dec 2019 | 27,500 | 27,500 | - | - | Option to Purchase Common Stock | ||
| Christopher M. Fashek | Director | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 20 Nov 2019 | 25,000 | 25,000 (0%) | 0% | 2 | 50,000 | Common Stock |
| Stephen R. Brown | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 22,500 | 22,500 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 22,083 | 22,083 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 32,500 | 32,500 | - | - | Option to Purchase Common Stock | |
| Christopher M. Fashek | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 45,000 | 45,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 22,500 | 22,500 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 20,417 | 20,417 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | None | 14 Aug 2018 | 27,500 | 27,500 | - | - | Option to Purchase Common Stock | ||
| Michael Ferguson | None | 14 Aug 2018 | 21,250 | 21,250 | - | - | Option to Purchase Common Stock | ||
| Brian M. Murphy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2018 | 75,000 | 75,000 | - | - | Option to Purchase Common Stock | |
| Christopher M. Fashek | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2016 | 91,679 | 91,679 | - | - | Option to Purchase Common Stock | |
| Thomas R. Mika | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2016 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
| Ira A. Greenstein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2016 | 40,000 | 40,000 | - | - | Option to Purchase Common Stock | |
| Martin Goldstein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2016 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock | |
| Michael Ferguson | None | 18 Jul 2016 | 20,000 | 20,000 | - | - | Option to Purchase Common Stock |